2024 annual financial data
Anika Therapeutics 2024 Operating margin
Direct answer
Operating margin was -4.25%.
Operating income was -5.1M USD and net income was -56.39M USD.
Operating cash flow was 5.4M USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 119.91M USD
- Operating income
- -5.1M USD
- Net income
- -56.39M USD
- Operating cash flow
- 5.4M USD